Table 6.
Hormone status at onset of Mal de Debarquement Syndrome (MdDS).
| Motion triggered (MT) | Non-MT | p-Value | |
|---|---|---|---|
| Total (%) n = 65 | Total (%) n = 31 | ||
| Premenstrual MdDS onset | 28 (43%) | 14 (45%) | 0.8474 |
| Age of menarche years (SD) | 12.8 (1.3) | 12.6 [1.1] | 0.4617 |
| Effect of menses | |||
| Sx worse perimenstrual | 20 (71%) | 10 (71%) | 0.6309 |
| Sx better perimenstrual | 1 (4%) | 1 (7%) | |
| Post-menopausal MdDS onset | 37 (57%) | 17 (55%) | 0.8474 |
| Age of menopause (SD) | 47.3 (8.2) | 44.8 [8.9] | 0.3157 |
| MdDS onset during hormone transitions | |||
| Perimenopausea | 22 (34%) | 6 (20%) | 0.2223 |
| Pregnancy | 2 (3%) | 1 (3%) | 1.000 |
| Postpartum | 2 (3%) | 3 (10%) | 0.3243 |
| Wean from nursing | 2 (3%) | 1 (3%) | 1.000 |
| Oophorectomy | 2 (3%) | 1 (3%) | 1.000 |
| Contraception change | 1 (2%) | 4 (13%) | 0.0362 |
aHot flashes, night sweats, and vaginal dryness.